Antimicrobial prophylaxis in liver transplant patients - A multicenter survey endorsed by the European Liver and Intestine Transplant Association

Transplant International

Volumn 23, Issue 2, 2010, Pages 182-190

  Vandecasteele, Els ^a   De Waele, Jan ^a   Vandijck, Dominique ^a   Blot, Stijn ^a   Vogelaers, Dirk ^a   Rogiers, Xavier ^a   Van Vlierberghe, Hans ^a   Decruyenaere, Johan ^a   Hoste, Eric ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Antibiotic; Antifungal; Cytomegalovirus; Liver transplantation; Prophylaxis

Indexed keywords

AMPHOTERICIN B; BETA LACTAM ANTIBIOTIC; COTRIMOXAZOLE; FLUCONAZOLE; ITRACONAZOLE;

ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; HEALTH SURVEY; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MEDICAL SOCIETY; PRIORITY JOURNAL; RISK FACTOR; STRUCTURED QUESTIONNAIRE; TREATMENT RESPONSE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; EUROPE; HUMANS; INFECTION CONTROL; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; QUESTIONNAIRES; SOCIETIES, MEDICAL;

EID: 73449134825     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2009.00974.x     Document Type: Article

References (19)

1. Del Pozo JL. Update and actual trends on bacterial infections following liver transplantation. World J Gastroenterol 2008 14 : 4977.
2. Safdar N, Said A, Lucey MR. The role of selective digestive decontamination for reducing infection in patients undergoing liver transplantation: a systematic review and meta-analysis. Liver Transpl 2004 10 : 817.
3. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007 357 : 2601.
4. Huprikar S. Update in infectious diseases in liver transplant recipients. Clin Liver Dis 2007 11 : 337.
5. Singh N, Wagener MM, Obman A, Cacciarelli TV, de Vera ME, Gayowski T. Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens. Liver Transpl 2004 10 : 844.
6. Newell KA, Millis JM, Arnow PM, et al. Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. Transplantation 1998 65 : 439.
7. Singh N, Paterson DL, Chang FY, et al. Methicillin-resistant Staphylococcus aureus: the other emerging resistant gram-positive coccus among liver transplant recipients. Clin Infect Dis 2000 30 : 322.
8. Torre-Cisneros J, Herrero C, Canas E, Reguera JM, De La Mata M, Gomez-Bravo MA. High mortality related with Staphylococcus aureus bacteremia after liver transplantation. Eur J Clin Microbiol Infect Dis 2002 21 : 385.
9. Silveira FP, Husain S. Fungal infections in solid organ transplantation. Med Mycol 2007 45 : 305.
10. Singh N. Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy. Clin Infect Dis 2000 31 : 545.
11. Cruciani M, Mengoli C, Malena M, Bosco O, Serpelloni G, Grossi P. Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis. Liver Transpl 2006 12 : 850.
12. Playford EG, Webster AC, Sorrell TC, Craig JC. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database of Syst Rev (Online) 2006 25 : CD004920.
13. Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004 38 : 161.
14. Blot S, Vandewoude K. Management of invasive candidiasis in critically ill patients. Drugs 2004 64 : 2159.
15. Singh N, Wagener MM, Cacciarelli TV, Levitsky J. Antifungal management practices in liver transplant recipients. Am J Transplant 2008 8 : 426.
16. Singh N. Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence. Clin Infect Dis 2005 40 : 704.
17. Small LN, Lau J, Snydman DR. Preventing post-organ transplantation cytomegalovirus disease with ganciclovir: a meta-analysis comparing prophylactic and pre-emptive therapies. Clin Infect Dis 2006 43 : 869.
18. Gane E, Saliba F, Valdecasas GJ, et al. Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected]. Lancet 1997 350 : 1729.
19. Levitsky J, Singh N, Wagener MM, Stosor V, Abecassis M, Ison MG. A survey of CMV prevention strategies after liver transplantation. Am J Transplant 2008 8 : 158.